Immunotherapy is redefining survivorship to include an increasing population of patients who live with cancer and navigate toxicities that differ from those that accompany traditional treatments.
Find the CANCER BUZZ podcast on Apple Podcasts, Spotify, or wherever you get your podcasts!
Immunotherapy is redefining survivorship to include an increasing population of patients who live with cancer and navigate toxicities that differ from those that accompany traditional treatments. In this episode, CANCER BUZZ speaks with Brittney Baer, BSN, RN, patient care coordinator for the Immune Effector Cell program at Vanderbilt University Medical Center’s Vanderbilt-Ingram Cancer Center, about key strategies and solutions to prioritize patient quality of life by addressing barriers to holistic survivorship care.
“I think simply talking to your patients and seeing what they would like to see [in terms of survivorship care] out of your cancer center—you don't have to start a huge holistic program right away...whether it be a nutritional program, a one-day-a-week meditation class, or a yoga class...start small and then start growing from there.”—Brittney Baer, BSN, RN
Guests:
Brittney Baer, BSN, RN
Patient Care Coordinator, Immune Effector Cells
Vanderbilt University Medical Center - Vanderbilt-Ingram Cancer Center
Nashville, TN
This episode was made possible by support from Bristol Myers Squibb and developed in connection with ACCC’s Immuno-Oncology Institute, which is made possible by support from Bristol Myers Squibb, Merck & Co., and AstraZeneca.
Resources:
The views and opinions expressed herein are those of the author(s)/faculty member(s) and do not reflect the official policy or position of their employer(s) or the Association of Cancer Care Centers.
July 8, 2026
June 30, 2026
At the 2026 ASCO Annual Meeting, the Louisiana Oncology Society received the ASCO Jeffrey C Ward Affiliate Advocacy Award for advancing critical advocacy priorities that have translated into meaningful legislative victories. The Iowa Oncology Society and Washington State Medical Oncology Society were also recognized for their advocacy efforts in 2025 at the meeting, receiving second place awards.
